Adverse events700

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 700

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 85 mg/m^2	2	5	7
other	Anaemia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 70 mg/m^2	7	25	11
other	Anaemia	Blood and lymphatic system disorders	Part 2: Irinotecan Liposome Injection 70 mg/m^2	82	226	193
other	Anaemia	Blood and lymphatic system disorders	Part 2: Topotecan 1.5 mg/m^2	177	223	773
other	Neutropenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 85 mg/m^2	3	5	3
other	Neutropenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 70 mg/m^2	4	25	7
other	Neutropenia	Blood and lymphatic system disorders	Part 2: Irinotecan Liposome Injection 70 mg/m^2	41	226	124
other	Neutropenia	Blood and lymphatic system disorders	Part 2: Topotecan 1.5 mg/m^2	137	223	532
other	Thrombocytopenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 85 mg/m^2	0	5	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 70 mg/m^2	4	25	11
other	Thrombocytopenia	Blood and lymphatic system disorders	Part 2: Irinotecan Liposome Injection 70 mg/m^2	11	226	20
other	Thrombocytopenia	Blood and lymphatic system disorders	Part 2: Topotecan 1.5 mg/m^2	131	223	487
other	Leukopenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 85 mg/m^2	0	5	0
other	Leukopenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 70 mg/m^2	0	25	0
other	Leukopenia	Blood and lymphatic system disorders	Part 2: Irinotecan Liposome Injection 70 mg/m^2	29	226	82
other	Leukopenia	Blood and lymphatic system disorders	Part 2: Topotecan 1.5 mg/m^2	94	223	397
other	Lymphopenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 85 mg/m^2	1	5	3
other	Lymphopenia	Blood and lymphatic system disorders	Part 1: Irinotecan Liposome Injection 70 mg/m^2	1	25	5
other	Lymphopenia	Blood and lymphatic system disorders	Part 2: Irinotecan Liposome Injection 70 mg/m^2	22	226	54
other	Lymphopenia	Blood and lymphatic system disorders	Part 2: Topotecan 1.5 mg/m^2	27	223	133

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03088813/events

API reference For AI assistants

Adverse events700

Sources 3

Read this list from software.